These 3 models—Global Benchmark for Efficient Drug Pricing (GLOBE), Guarding US Medicare Against Rising Drug Costs (GUARD), and Generating Cost Reductions for US Medicaid (GENEROUS)—apply most-favored-nation (MFN) pricing logic across Medicare Part B, …
Source link
